{
  "main_header": {
    "sid": 936506,
    "name": "Bharat Immunolog",
    "stock_name": "Bharat Immunolog",
    "full_name": "Bharat Immunological & Biological Corporation Ltd",
    "name_url": "stocks-analysis/bharat-immunolog",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "17.10",
    "chg": 0.05,
    "chgp": "0.29%",
    "dir": 1,
    "prev_price": "17.05",
    "mcapval": "73.84 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524663,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE994B01014",
    "curr_date": "Jun 18",
    "curr_time": "",
    "bse_nse_vol": "8.14 k",
    "exc_status": "Active",
    "traded_date": "Jun 18, 2026",
    "traded_date_str": "2026 06 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/bharat-immunolog-936506-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Bharat Immunological & Biological Corporation Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bharat-immunological-biological-corporation-ltd-is-rated-strong-sell-3955841",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/BharatImmunolog_mojoScore_3955841.png",
        "date": "2026-04-21 10:10:18",
        "description": "Bharat Immunological & Biological Corporation Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 09 Apr 2024, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics discussed here represent the company’s current position as of 21 April 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical standing."
      },
      {
        "title": "Bharat Immunological & Biological Corporation Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bharat-immunological-biological-corporation-ltd-is-rated-strong-sell-3941477",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/BharatImmunolog_mojoScore_3941477.png",
        "date": "2026-04-10 10:10:44",
        "description": "Bharat Immunological & Biological Corporation Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 09 Apr 2024. However, the analysis and financial metrics presented here reflect the company’s current position as of 10 April 2026, providing investors with an up-to-date view of its fundamentals, returns, and market standing."
      },
      {
        "title": "Bharat Immunological & Biological Corporation Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bharat-immunological-biological-corporation-ltd-is-rated-strong-sell-3923796",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/BharatImmunolog_mojoScore_3923796.png",
        "date": "2026-03-30 10:10:17",
        "description": "Bharat Immunological & Biological Corporation Ltd is rated 'Strong Sell' by MarketsMOJO, with this rating last updated on 09 April 2024. However, the analysis and financial metrics discussed here reflect the stock's current position as of 30 March 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "Bharat Immunological & Biological Corporation Ltd Falls to 52-Week Low of Rs 15.55 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bharat-immunological-biological-corporation-ltd-hits-52-week-low-amidst-continued-downtrend-3919806",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/BharatImmunolog_priceRelatedfactors_3919806.png",
        "date": "2026-03-27 13:49:19",
        "description": "A sharp decline of 4.29% today dragged Bharat Immunological & Biological Corporation Ltd to a fresh 52-week low of Rs 15.55, extending its downward trajectory despite a brief two-day rally. This fall comes amid a broader market weakness, but the stock’s underperformance is notably more severe than its sector peers."
      }
    ],
    "total": 11,
    "sid": "936506",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/bharat-immunological-biological-corporation-936506"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Intimation Of Date Of Board Meeting On 16.08.2024 Under Regulation 29 Of SEBIS LODR.",
      "datetime": "07-Aug-2024",
      "details": "BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/08/2024 inter alia to consider and approve Pursuant to the Regulation 29 and other applicable Regulation(s) of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations 2015 it is informed that a meeting of the Board of Directors of the Company is scheduled to be held on Friday 16th August 2024 for General Purpose.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Intimation Of Date Of Board Meeting On 08.03.2024 Under Regulation 29 Of SEBIS LODR.",
      "datetime": "29-Feb-2024",
      "details": "BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/03/2024 inter alia to consider and approve Pursuant to the Regulation 29 and other applicable Regulation(s) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 it is informed that a meeting of the Board of Directors of the Company is scheduled to be held on Friday 08th March 2024 for General Purpose.",
      "source": "BSE"
    },
    {
      "caption": "Compliance Of Regulation 34 Of LODR 2015 And Submission Annual Report For 34Th Annual General Meeting Scheduled On 29.12.2023.",
      "datetime": "13-Dec-2023",
      "details": "Submission of Draft Annual Report 2022-23 for AGM on 29.12.2023",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Bharat Immunological & Biological Corporation Ltd is Rated Strong Sell

2026-04-21 10:10:18

Bharat Immunological & Biological Corporation Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 09 Apr 2024, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics discussed here represent the company’s current position as of 21 April 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical standing.

Read More

Bharat Immunological & Biological Corporation Ltd is Rated Strong Sell

2026-04-10 10:10:44

Bharat Immunological & Biological Corporation Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 09 Apr 2024. However, the analysis and financial metrics presented here reflect the company’s current position as of 10 April 2026, providing investors with an up-to-date view of its fundamentals, returns, and market standing.

Read More

Bharat Immunological & Biological Corporation Ltd is Rated Strong Sell

2026-03-30 10:10:17

Bharat Immunological & Biological Corporation Ltd is rated 'Strong Sell' by MarketsMOJO, with this rating last updated on 09 April 2024. However, the analysis and financial metrics discussed here reflect the stock's current position as of 30 March 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Read More

Bharat Immunological & Biological Corporation Ltd Falls to 52-Week Low of Rs 15.55 as Sell-Off Deepens

2026-03-27 13:49:19

A sharp decline of 4.29% today dragged Bharat Immunological & Biological Corporation Ltd to a fresh 52-week low of Rs 15.55, extending its downward trajectory despite a brief two-day rally. This fall comes amid a broader market weakness, but the stock’s underperformance is notably more severe than its sector peers.

Read More

View All News